IGF-1 DES
Also known as: DES IGF-1 · Des(1-3) IGF-1
A truncated IGF-1 variant with enhanced receptor binding affinity due to removal of the first three amino acids.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~20–30 minutes
50–100 mcg
Subcutaneous or intramuscular injection
Mechanism of Action
Binds IGF-1 receptors with higher affinity than native IGF-1 due to reduced IGFBP binding, producing potent anabolic effects.
Key Research Areas
Frequently Asked Questions
What is IGF-1 DES?▾
How does IGF-1 DES work?▾
What is the recommended dosage for IGF-1 DES?▾
What is the half-life of IGF-1 DES?▾
Is IGF-1 DES FDA approved?▾
Ready to get started with IGF-1 DES?
Order from our COA-verified partner — free US shipping, pharmaceutical-grade quality.
Research Disclaimer
The information provided about IGF-1 DES is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.